Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03361033 · ClinicalTrials.gov registry record

Components of Social Functioning in Survivors of Pediatric Brain Tumors

A clinical trial of Brain Tumor, Pediatric and Medulloblastoma, Pediatric, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
80
Enrollment target
1
Study location

NCT03361033 is a study of Brain Tumor, Pediatric and Medulloblastoma, Pediatric that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03361033, a study of Brain Tumor, Pediatric and Medulloblastoma, Pediatric, has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

Children with brain tumors are at risk for a number of psychological late effects, including neurocognitive and social deficits. This observational study focuses on assessment of social functioning, including social-cognitive and neurocognitive abilities, in survivors of pediatric brain tumors. This study will also assess the influence of medical factors, including diagnosis and age at diagnosis, on social functioning. PRIMARY OBJECTIVE: Examine the impact of social-cognitive and neurocognitive abilities on social functioning in survivors of pediatric brain tumors. SECONDARY OBJECTIVE: Assess the influence of medical factors such as diagnosis and age at diagnosis on the social functioning of survivors of pediatric brain tumors.

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2018-01-30
Est. Completion 2022-10-17

What the Registry Record Tells You About NCT03361033

The ClinicalTrials.gov registry entry for NCT03361033 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Brain Tumor, Pediatric appearing as the primary indexed condition, and to 0 interventions.

NCT03361033 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03361033 about?

NCT03361033 is a clinical study titled "Components of Social Functioning in Survivors of Pediatric Brain Tumors". Children with brain tumors are at risk for a number of psychological late effects, including neurocognitive and social deficits. This observational study focuses on assessment of social functioning, including social-cognitive and neurocognitive abilities, in survivors of pediatric brain tumors. This...

What is the current status of trial NCT03361033?

This trial is currently completed. The enrollment target is 80 participants. The study started on 2018-01-30. Estimated completion is 2022-10-17.

What conditions does trial NCT03361033 study?

This clinical trial studies the following conditions: Brain Tumor, Pediatric, Medulloblastoma, Pediatric.

Who is sponsoring clinical trial NCT03361033?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03361033 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Tumor, Pediatric

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.